Fund
OrbiMed
Page built from the operations logged, not from a written profile. It says nothing about the fund's activity outside the scope of Bolus, which is health venture capital in Europe and the United States.
- Operations logged
- 4
- Lead
- 2
- New entries
- 2
- Follow ons
- 0
- Latest operation
- 17 September 2026
- Sectors
- Biotech, Medtech
Operations
| Date | Company | Stage | Amount | Role |
|---|---|---|---|---|
| 17 Sept | Canada | Series A | 25 M$ | Lead |
| 17 Aug | United States, Biotech | Series A | 30 M$ | Participant |
| 06 Feb | United States, Biotech | Series D and later | 130 M$ | Participant |
| 12 Jan | Israel, Medtech | Series B | 50 M$ | Lead |
Co investors 24 funds crossed
- Alexandria Venture Investments 1 operation
- Ally Bridge Group 1 operation
- Ascenta Capital 1 operation
- Bain Capital Life Sciences 1 operation
- Benchstrength 1 operation
- BlackRock 1 operation
- BVF Partners 1 operation
- Chugai Venture Fund 1 operation
- Elevage Medical 1 operation
- Eli Lilly and Company 1 operation
- Euclidean Capital 1 operation
- Frazier Life Sciences 1 operation
- Fusion Fund 1 operation
- Hillhouse Investment 1 operation
- Innovation Endeavors 1 operation
- Logos Capital 1 operation
- Lumira Ventures 1 operation
- Newpath Partners 1 operation
- PhiFund 1 operation
- Qiming Venture Partners USA 1 operation
- RA Capital Management 1 operation
- SV Health Investors Dementia Discovery Fund 1 operation
- Venrock Healthcare Capital Partners 1 operation
- Wellington Management 1 operation
Funds that appeared in the same rounds, in any capacity. Geographies logged: Canada, United States, Israel.